Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Chem Sci ; 7(4): 2706-2710, 2016 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-28660044

RESUMO

A synthesis of the bioactive indolocarbazole alkaloid K-252c (staurosporinone) via a sequential C-H functionalisation strategy is reported. The route exploits direct functionalisation reactions around a simple arene core and comprises of two highly-selective copper-catalysed C-H arylations, a copper-catalysed C-H amination and a palladium-catalysed C-H carbonylation, which build up the structural complexity of the natural product framework.

2.
Chem Sci ; 6(2): 1277-1281, 2015 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-29541441

RESUMO

A mild and transition metal-free counteranion triggered arylation strategy has been developed using diaryliodonium fluorides. The fluoride counteranion within the hypervalent iodonium species displays unusual reactivity that activates a phenolic O-H bond leading to electrophilic O-arylation. A wide range of phenols and diaryliodonium salts are compatible with this transformation under remarkably mild conditions. Furthermore, we pre-empt the wider implications of this strategy by demonstrating the compatibility of the arylation tactic with latent carbon nucleophiles.

3.
J Clin Pharm Ther ; 27(3): 169-83, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12081630

RESUMO

The prevailing major theory of Alzheimer's disease (AD) is that insoluble amyloid beta-peptide (Abeta) found in the cerebral plaques characteristic of the disease is causative or is at least a contributing factor. According to this theory, inhibition of aberrant Abeta production should prevent or at least limit the extent of AD pathophysiology. As three 'secretase' enzymes (alpha, beta and gamma) catalyse the proteolytic cleavage of amyloid precursor protein (APP) (the precursor protein of Abeta), one or more secretases have become targets for potential novel AD pharmacotherapy. Secretase inhibitors have been designed and are in various stages of development. The clinical trials of these compounds will, if positive, result in drugs with dramatically better clinical efficacy or, if negative, will force a reassessment of the theory about the role of Abeta in AD.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/enzimologia , Sistemas de Liberação de Medicamentos , Endopeptidases/metabolismo , Inibidores de Proteases/uso terapêutico , Doença de Alzheimer/patologia , Secretases da Proteína Precursora do Amiloide , Peptídeos beta-Amiloides/metabolismo , Ácido Aspártico Endopeptidases , Humanos , Emaranhados Neurofibrilares/patologia , Placa Amiloide/patologia
4.
Org Lett ; 3(1): 25-8, 2001 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-11429862

RESUMO

[figure: see text] A conceptually new palladium-catalyzed amidation reaction is described for the synthesis of beta-amido ketones based on derailing the Wacker oxidation of enones. This reaction generates a new carbon-nitrogen bond via a palladium-catalyzed conjugate addition of a carbamate nucleophile to an enone. The regiocontrol, mild and neutral conditions, lack of preactivation of the nucleophile, and lack of reoxidation system for the catalyst are attractive features of this transformation.


Assuntos
Amidas/química , Amidas/síntese química , Catálise , Cetonas/síntese química , Paládio/química , Aminoácidos/química , Venenos de Anfíbios/química , Carbamatos/química , Estrutura Molecular , Oxirredução , Estereoisomerismo , Relação Estrutura-Atividade
5.
Chem Commun (Camb) ; (18): 1844-5, 2001 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-12240343

RESUMO

The allylic hydrogen is found to have a dramatic effect on the regioselectivity of the Wacker oxidation, leading to the postulation that an agostic hydrogen or enyl (sigma + pi) complex helps to stabilise the key intermediate.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA